1. Department of Pulmonary Medicine and
2. Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands;
3. Amsterdam Public Health, Amsterdam, the Netherlands;
4. Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt;
5. Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital,
6. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, and
7. Department of Paediatric Pulmonary Medicine, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands;
8. Department of Food Science, University of Copenhagen, Frederiksberg, Denmark;
9. Section of Microbiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark;
10. Novozymes, Bagsvaerd, Denmark;
11. Section of Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark;
12. National Heart and Lung Institute, Imperial College London, London, United Kingdom;
13. Royal Brompton and Harefield NHS Trust, London, United Kingdom;
14. Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom;
15. Manchester Academic Health Science Centre and National Institute for Health and Care Research Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom;
16. University Children’s Hospital Basel, University of Basel, Basel, Switzerland;
17. Division of Paediatric Pulmonology and Allergology, Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria;
18. Division of Paediatric Respiratory Medicine and Allergology, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;
19. Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden;
20. Department of Women’s and Children’s Health, Karolinska Institute, Stockholm, Sweden;
21. National Institute for Health and Care Research Respiratory Biomedical Research Unit, University of Nottingham, Nottingham, United Kingdom;
22. National Institute for Health and Care Research Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and Clinical and Experimental Sciences and Human Development and Health, University of Southampton, Southampton, United Kingdom;
23. European Institute for Systems Biology and Medicine, CIRI UMR5308, CNRS-ENS-UCBL-INSERM, Lyon, France;
24. Acclarogen Ltd., St. John’s Innovation Centre, Cambridge, United Kingdom;
25. Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, United Kingdom;
26. BioSci Consulting, Maasmechelen, Belgium; and
27. Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands